AU2003294728A1 - DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) - Google Patents

DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)

Info

Publication number
AU2003294728A1
AU2003294728A1 AU2003294728A AU2003294728A AU2003294728A1 AU 2003294728 A1 AU2003294728 A1 AU 2003294728A1 AU 2003294728 A AU2003294728 A AU 2003294728A AU 2003294728 A AU2003294728 A AU 2003294728A AU 2003294728 A1 AU2003294728 A1 AU 2003294728A1
Authority
AU
Australia
Prior art keywords
pde9a2
therapeutics
diagnostics
diseases associated
human phosphodiesterase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003294728A
Inventor
Ulf Bruggemeier
Andreas Geerts
Stefan Golz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003294728A1 publication Critical patent/AU2003294728A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
AU2003294728A 2002-12-09 2003-11-26 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) Abandoned AU2003294728A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027532.7 2002-12-09
EP02027532 2002-12-09
PCT/EP2003/013280 WO2004053494A1 (en) 2002-12-09 2003-11-26 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)

Publications (1)

Publication Number Publication Date
AU2003294728A1 true AU2003294728A1 (en) 2004-06-30

Family

ID=32479718

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003294728A Abandoned AU2003294728A1 (en) 2002-12-09 2003-11-26 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)

Country Status (3)

Country Link
EP (1) EP1573333A1 (en)
AU (1) AU2003294728A1 (en)
WO (1) WO2004053494A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2672591A1 (en) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. Treating agent of uropathy
PE20110383A1 (en) * 2008-09-08 2011-07-15 Boehringer Ingelheim Int PYRAZOLOPYRIMIDINONES AS INHIBITORS OF PHOSPHODIESTERASE 9A (PDE9A)
KR101695866B1 (en) * 2009-05-12 2017-01-13 코닌클리케 필립스 엔.브이. Phosphodiesterase 9a as prostate cancer marker

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002504341A (en) * 1998-02-23 2002-02-12 アイコス コーポレイション Phosphodiesterase 10

Also Published As

Publication number Publication date
EP1573333A1 (en) 2005-09-14
WO2004053494A1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
AU2003251471A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5)
AU2003276220A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a)
AU2003301894A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d)
AU2003229735A1 (en) Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
AU2003276136A1 (en) Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1)
AU2003294728A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)
AU2003283303A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
AU2003205627A1 (en) Diagnostics and therapeutics for diseases associated with gpr72
AU2003283427A1 (en) Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
AU2003279361A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b)
AU2003274083A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a)
AU2003267380A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a)
AU2003288171A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3)
AU2003288158A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c)
AU2003289894A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4)
AU2003279323A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b)
AU2003282087A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1)
AU2003276187A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a)
AU2003274082A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a)
AU2003279322A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3)
AU2003301913A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2)
AU2003283302A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1)
AU2003218638A1 (en) Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
AU2003250221A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6)
AU2003267443A1 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase